Provided by Tiger Trade Technology Pte. Ltd.

B. Riley

3.96
-0.0300-0.75%
Post-market: 3.92-0.0400-1.01%18:36 EST
Volume:442.68K
Turnover:1.76M
Market Cap:121.16M
PE:-0.16
High:4.05
Open:3.99
Low:3.84
Close:3.99
52wk High:7.90
52wk Low:2.67
Shares:30.60M
Float Shares:16.01M
Volume Ratio:0.64
T/O Rate:2.77%
Dividend:0.50
Dividend Rate:12.62%
EPS(TTM):-24.1187
EPS(LYR):-25.4591
ROE:-3385.42%
ROA:-26.41%
PB:-0.24
PE(LYR):-0.16

Loading ...

B. Riley Adjusts Sound Point Meridian Capital Price Target to $16 From $23, Maintains Buy Rating

MT Newswires Live
·
Nov 20

B. Riley Adjusts Price Target on Carlyle Credit Income Fund A to $6 From $9, Maintains Buy Rating

MT Newswires Live
·
Nov 20

Sequans price target lowered to $11 from $13 at B. Riley

TIPRANKS
·
Nov 20

B. Riley Adjusts FG Nexus Price Target to $5 From $8, Maintains Buy Rating

MT Newswires Live
·
Nov 20

B. Riley Adjusts Price Target on BitMine Immersion to $47 From $90, Maintains Buy Rating

MT Newswires Live
·
Nov 20

Gladstone Capital Shares Rise After Upgrades From B. Riley, Oppenheimer

MT Newswires Live
·
Nov 20

B. Riley Financial granted request to continue listing on Nasdaq

TIPRANKS
·
Nov 20

B. Riley Financial Granted Nasdaq Extension to Cure Filing Delinquencies

Reuters
·
Nov 20

Varex Imaging Price Target Maintained With a $16.00/Share by B. Riley Securities

Dow Jones
·
Nov 20

Nuvation Bio Shares Surge After B. Riley Initiates Coverage at Buy

MT Newswires Live
·
Nov 20

B. Riley Upgrades Gladstone Capital to Buy From Neutral, Adjusts Price Target to $22 From $27

MT Newswires Live
·
Nov 19

B. Riley Initiates Coverage on Nuvation Bio With Buy Rating, $12 Price Target

MT Newswires Live
·
Nov 19

Nuvation Bio initiated with a Buy at B. Riley

TIPRANKS
·
Nov 19

Gladstone Capital upgraded to Buy from Neutral at B. Riley

TIPRANKS
·
Nov 19

B Riley Financial: Q1 2025 REV $186.1 Mln, Loss per Share $0.39 - SEC Filing

THOMSON REUTERS
·
Nov 19

Press Release: B. Riley Financial Reports First Quarter 2025 Results

Dow Jones
·
Nov 19

Perspective Therapeutics Is Maintained at Buy by B. Riley Securities

Dow Jones
·
Nov 19

BitFuFu price target lowered to $6 from $7 at B. Riley

TIPRANKS
·
Nov 18

Onto Innovation price target raised to $180 from $173 at B. Riley

TIPRANKS
·
Nov 18

Tango Therapeutics price target raised to $14 from $8 at B. Riley

TIPRANKS
·
Nov 18